Literature DB >> 20852865

[Familial thyroid carcinomas].

K W Schmid1, S Ting, S-Y Sheu.   

Abstract

Approximately 5% of differentiated thyroid carcinomas with follicular cell differentiation, papillary thyroid carcinoma (PTC) and follicular thyroid carcinoma (FTC) and 25-30% of medullary thyroid carcinoma (MTC) are hereditary. They occur either as part of a defined syndrome or are confined to the thyroid gland. Compared to their sporadic non-hereditary counterparts hereditary thyroid carcinomas generally develop earlier and regularly show multifocal tumour growth. With the exception of familial MTC, which is preceded by neoplastic C cell hyperplasia, no precursor lesions of hereditary thyroid carcinoma are known. In strong correlation with the localisation of the germline mutation of the RET protooncogene, familial MTC shows a distinct clinical course which allows precise clinical decision-making for prophylactic thyroidectomy to prevent invasive MTC. According to current knowledge prophylactic thyroidectomy of all other types of hereditary thyroid carcinoma is not justified.

Entities:  

Mesh:

Year:  2010        PMID: 20852865     DOI: 10.1007/s00292-010-1360-8

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  16 in total

1.  Is screening for thyroid carcinoma indicated in familial adenomatous polyposis? The Leeds Castle Polyposis Group.

Authors:  C Bülow; S Bülow
Journal:  Int J Colorectal Dis       Date:  1997       Impact factor: 2.571

2.  On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindreds.

Authors:  N David Charkes
Journal:  Thyroid       Date:  2006-02       Impact factor: 6.568

3.  Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.

Authors:  D Liaw; D J Marsh; J Li; P L Dahia; S I Wang; Z Zheng; S Bose; K M Call; H C Tsou; M Peacocke; C Eng; R Parsons
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

4.  Unusual features of thyroid carcinomas in Japanese patients with Werner syndrome and possible genotype-phenotype relations to cell type and race.

Authors:  Y Ishikawa; H Sugano; T Matsumoto; Y Furuichi; R W Miller; M Goto
Journal:  Cancer       Date:  1999-03-15       Impact factor: 6.860

Review 5.  Familial nonmedullary thyroid neoplasia.

Authors:  H Rubén Harach
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

6.  [Multiple endocrine neoplasia type 2].

Authors:  S-Y Sheu; K W Schmid
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

7.  Familial papillary thyroid carcinoma: genetics, criteria for diagnosis, clinical features, and surgical treatment.

Authors:  T J Musholt; P B Musholt; T Petrich; G Oetting; W H Knapp; J Klempnauer
Journal:  World J Surg       Date:  2000-11       Impact factor: 3.352

Review 8.  [Hereditary thyroid cancer].

Authors:  H Dralle; A Machens; K Lorenz
Journal:  Chirurg       Date:  2008-11       Impact factor: 0.955

Review 9.  Familial thyroid carcinoma: a diagnostic algorithm.

Authors:  Jorge Dotto; Vânia Nosé
Journal:  Adv Anat Pathol       Date:  2008-11       Impact factor: 3.875

Review 10.  An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up.

Authors:  Rebecca S Sippel; Nadine R Caron; Orlo H Clark
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

View more
  2 in total

Review 1.  [Clinical importance of thyroid gland cytology].

Authors:  S Ting; S Synoracki; A Bockisch; D Führer; K W Schmid
Journal:  Pathologe       Date:  2015-11       Impact factor: 1.011

Review 2.  German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.

Authors:  Henning Dralle; Thomas J Musholt; Jochen Schabram; Thomas Steinmüller; Andreja Frilling; Dietmar Simon; Peter E Goretzki; Bruno Niederle; Christian Scheuba; Thomas Clerici; Michael Hermann; Jochen Kußmann; Kerstin Lorenz; Christoph Nies; Peter Schabram; Arnold Trupka; Andreas Zielke; Wolfram Karges; Markus Luster; Kurt W Schmid; Dirk Vordermark; Hans-Joachim Schmoll; Reinhard Mühlenberg; Otmar Schober; Harald Rimmele; Andreas Machens
Journal:  Langenbecks Arch Surg       Date:  2013-03-03       Impact factor: 3.445

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.